Market

IND relates to a novel molecule targetting prostate cancer

No extension in the deadlines set for price revision

Generics exports growth of nearly 30 per cent enabling greater research spend

Agreement signed with Kulim Hi Tech Park

ALZUMAb is being introduced in India by Biocon's Immuno Therapy Division

To launch the products in the western region of the country initially

Acamprosate is indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence

Signs agreement with Mylan

But growth back to double digits for products still out of price control

Summit to be held in Mumbai on September 27, 2013